Maternal Incarceration May Impact Adolescent Sleep
A study found that adolescents with maternal incarceration histories were significantly more likely to experience sleep difficulties, along with poorer diet and exercise habits.
Category: Sleep Maintenance Insomnia
Sleep Maintenance Insomnia
Latest
Sleep Maintenance Insomnia
LatestPhase 3 Study: DAYVIGO Improved Sleep Onset, Sleep Maintenance Compared with Placebo
JAMA Network Open has published results of SUNRISE 1 (Study 304), a pivotal Phase 3 head-to-head study that compared DAYVIGO (lemborexant), marketed by Eisai Inc, to placebo and an active comparator in patients with...
Sleep Maintenance Insomnia
LatestSorry, No Posts Found
Somnus Therapeutics Completes Successful Study of Sleep Maintenance Insomnia Drug
Somnus Therapeutics Inc, a private specialty pharmaceutical company, has completed a Phase 2 dose-ranging study of SKP-1041, a modified-release formulation of zaleplon. The study (SOM201), conducted in nonelderly adults with primary insomnia ch
Read MoreSilenor Commercially Available in the US
Silenor (doxepin), indicated for the treatment of insomnia characterized by difficulty with sleep maintenance, is now commercially available by prescription in the United States. Somaxon, maker of the insomnia treatment, has implemented a whole
Read MoreCompetitive Edge
Sleep medicine is a vibrant industry set on a path to expand. Not only do statistics support the growth outlook but the number of pharma companies eager to capture some of the market also indicate that companies are willing to...
Read MoreSomaxon Gains FDA Approval of Silenor for the Treatment of Insomnia
After a long and financially consuming process for Somaxon Pharmaceuticals, the US Food and Drug Administration (FDA) has approved the company’s New Drug Application (NDA) for Silenor (doxepin) for the treatment of insomnia characterized b
Read MoreTranscept Gearing Up to Resubmit Middle-of-the-night Insomnia Drug for FDA Approval
Transcept is anticipating further feedback from the FDA with regard to the activities necessary to resubmit the new drug application (NDA) for its middle-of-the-night insomnia treatment, Intermezzo. With cash, cash equivalents, and marketabl
Read MoreIntra-Cellular’s Insomnia Drug Meets Primary and Key Secondary Endpoints in Phase II Trial
Intra-Cellular Therapies Inc, New York, released final results from the Phase II trial of ITI-007 in patients with sleep maintenance insomnia. The trial showed ITI-007 significantly and dose-dependently increased slow wave sleep and decreased the d
Read MorePharmaceutical Research Roundup
Antidepressants Ease Pain for Fibromyalgia Patients An analysis of previous studies shows that the use of antidepressant medications by patients with fibromyalgia syndrome is associated with a reduction in pain, sleep disturbances, and depressed
Read MoreSuccessful Aging Linked to Normal Sleep
New research investigating sleep patterns of older women shows a link between normal sleep and healthy aging.
Read MoreTests for Insomnia Drug Underway
Intra-Cellular Therapies begins phase 1 clinical trials for ITI-722, a sleep maintenance insomnia treatment.
Read More
Sleep in Aging: Questions to Fulfill a Lifetime of Research
It is important to determine the consequences of age-related changes in all aspects of life in order to develop new strategies to help older individuals cope with sleep-wake cycle regularity challenges.
Read More